Imidazo[1,2-a]pyridines: A potent and selective class of cyclin-Dependent kinase inhibitors identified through structure-Based hybridisation-Reference-Cited by-同舟云学术

Imidazo[1,2-a]pyridines: A potent and selective class of cyclin-Dependent kinase inhibitors identified through structure-Based hybridisation

Published:2003-09 Issue:18 Volume:13 Page:3021-3026
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Anderson Malcolm,Beattie John F.,Breault Gloria A.,Breed Jason,Byth Kate F.,Culshaw Janet D.,Ellston Rebecca P.A.,Green Stephen,Minshull Claire A.,Norman Richard A.,Pauptit Richard A.,Stanway Judith,Thomas Andrew P.,Jewsbury Philip J.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference27 articles.

1. Cancer Cell Cycles

2. Anticancer drug targets: cell cycle and checkpoint control

3. Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists

4. Novel drugs targeting the cell cycle

5. Kimball, S. D.; Webster, K. R. In Annual Reports in Medicinal Chemistry; Doherty, A. M., Ed.; Academic: San Diego, 2001: Vol. 36, p 139, and references therein.

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and anticancer activity evaluation of some novel imidazo[1,2- a ]pyridine based heterocycles containing S -alkyl/aryl moiety;Phosphorus, Sulfur, and Silicon and the Related Elements;2024-05-03

2. Insights into the selectivity of a brain-penetrant CDK4/6 vs CDK1/2 inhibitor for glioblastoma used in multiple replica molecular dynamics simulations;Journal of Biomolecular Structure and Dynamics;2023-12-19

3. Recent Progress in CDK4/6 Inhibitors and PROTACs;Molecules;2023-12-13

4. Imidazopyridine-based kinase inhibitors as potential anticancer agents: A review;Bioorganic Chemistry;2023-11

5. Design, Synthesis, and Biological Evaluation of Novel 6,8-Disubstituted Imidazo[1,2-a]pyridine Derivatives as a CDK2 Inhibitors;HETEROCYCLES;2023